David L. Lahr
Io Therapeutics (United States)(US)Foghorn Therapeutics (United States)(US)
Publications by Year
Research Areas
Chromatin Remodeling and Cancer, Protein Degradation and Inhibitors, Gas Sensing Nanomaterials and Sensors, Computational Drug Discovery Methods, Bioinformatics and Genomic Networks
Most-Cited Works
- → A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles(2017)3,590 cited
- → High-throughput Phenotyping of Lung Cancer Somatic Mutations(2016)223 cited
- → Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map(2017)178 cited
- → A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations(2018)94 cited
- → Fabrication and gas sensing performance of parallel assemblies of metal oxide nanotubes supported by porous aluminum oxide membranes(2008)77 cited
- → Catalyzed CO Oxidation at 70 K on an Extended Au/Ni Surface Alloy(2006)62 cited